Sage Therapeutics, Inc. 4
4 · Sage Therapeutics, Inc. · Filed Dec 16, 2016
Insider Transaction Report
Form 4
Kanes Stephen
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-12-08+14,400→ 68,000 totalExercise: $38.25From: 2016-12-08Exp: 2025-01-23→ Common Stock (14,400 underlying)
Footnotes (1)
- [F1]The securities awarded on 1/23/2015 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 5,000 shares of common stock vested on the one year anniversary of the Vesting Start Date with 15,000 shares vesting in 36 equal monthly installments thereafter. Options to purchase 48,000 shares of common stock vest periodically over four years from the grant date upon the company reaching certain milestone requirements, of which the performance criteria were met with the respect of 14,400 shares.